Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 268 is one of many processed pseudogenes derived from the RN7SK gene, which encodes the functional 7SK small nuclear RNA. Functional 7SK snRNA is a critical regulator of transcriptional elongation in metazoans via sequestration of the positive transcription elongation factor b (P-TEFb); it plays roles in the control of RNA polymerase II activity and therefore gene expression. However, RN7SKP268 itself is a pseudogene—an inactive relic of evolutionary history that does not produce any functional RNA or protein and has no known role in normal physiology or disease. It is not considered a therapeutic target, nor is there any evidence it serves as a biomarker or has interacting drugs. Key clarification: RN7SK pseudogene 268 (RN7SKP268) should not be confused with the functional RN7SK snRNA, which is a well-studied regulatory RNA involved in transcriptional control in eukaryotes. The pseudogene copies like RN7SKP268 are typically nonfunctional, lack expression, and are not the subject of drug-development efforts. If a therapeutic context involving 7SK snRNA was meant, only the parent functional gene (RN7SK, not RN7SKP268) would be relevant.
none
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 268 (RN7SKP268).